Introduction
MHC class II (MHCII) molecules are peptide receptors that present antigenic peptides on the cell surface of antigenpresenting cells to CD4 + T cells. MHCII ␣ and ␤ subunits assemble in the ER with the chaperone invariant chain (Ii) (Anderson and Miller, 1992) . Ii binds to the peptide-binding groove and promotes folding and transport of the ␣␤ heterodimer (Amigorena et al., 1995) . Assembly with Ii alters the conformation of the MHCII heterodimer (Verreck et al., 2001) . This conformational change of MHCII molecules may initiate intracellular transport and subsequent maturation of the class II peptide receptors.
An additional role of Ii is to sort MHCII heterodimers to endocytic compartments (Bakke and Dobberstein, 1990) . A signal sequence on the cytoplasmic tail of Ii guides MHCII molecules to endocytic vesicles, where internalized antigen is encountered (Bremnes et al., 1994) . Upon release of Ii in MHCII vesicles, antigenic peptides are bound to the class II cleft (Roche and Cresswell, 1991) . Mice with an interrupted Ii gene show reduced MHCII surface expression and are deficient in presenting antigen, which indicates that Ii plays an important role in the MHCII-processing pathway (Elliott et al., 1994; Viville et al., 1993) . Investigation of proteolytic processing of the MHCII/Ii complex in endocytic vesicles revealed that after digestion, a fragment of Ii (class-II-associated Ii peptide or CLIP), remains bound to the MHCII cleft. CLIP is subsequently released by DM molecules from the MHCII heterodimer. The X-ray structure of HLA-DR3 with bound CLIP demonstrated that the Ii-derived peptide is lodged in the MHCII peptidebinding groove (Ghosh et al., 1995) . CLIP binds like antigenic peptides to the MHCII cleft (Malcherek et al., 1995) . Polymorphic residues in the ␣1␤1 domain of MHCII heterodimers modulate the binding affinity to CLIP (Sette et al., 1995) . Transfection of different combinations of MHCII alloand isotypes into fibroblast cells revealed a varying efficiency of cell-surface expression (Sant et al., 1991) . Later studies indicated that the CLIP segment in Ii regulates assembly and intracellular transport of the class II heterodimers (Romagnoli and Germain, 1994) . The contact of Ii to polymorphic side chains in the class II groove suggests that varying degrees of Ii dependency occur during class II subunit assembly (Bikoff et al., 1995) . However, to achieve a chaperone role of Ii for all MHCII allo-and isotypes, interaction of Ii to a conserved region of the MHCII heterodimer is required. Previously, it was shown that a proline-rich sequence of Ii stabilizes binding of Ii to the MHCII heterodimer (Stumptner and Benaroch, 1997) . Amino acid residues 82-86 of Ii mediate promiscuous binding to the MHCII polypeptides (Siebenkotten et al., 1998) . The interaction site of this proline-rich sequence of Ii on DR molecules has not been identified. The residues Pro82, Pro84, Pro85 and Pro87 of Ii are adjacent to the ␣ 2 ␤ 2 domain of DR and could interact to a conserved region of the class II polypeptides. We searched for a proline-binding structure on MHCII heterodimers.
In this study a conserved sequence on MHCII ␤ chains was discovered, which contains two tryptophan residues that form in their three-dimensional structure parallel sheets with tyrosine residues. One pair of Trp and Tyr and an adjacent Asp residue on DR␤ chain mediate contact to a proline-rich sequence of Ii. The interaction of Ii to this novel motif on
The human lymphocyte antigen (HLA) class II region encodes highly polymorphic peptide receptors, which associate in the ER to the chaperone invariant chain (Ii). Ii facilitates assembly of class II subunits to functional peptide receptors. We searched for a conserved structure on HLA-DR polypeptides that mediates contact to a previously identified proline-rich class-II-binding sequence of Ii. Major histocompatibility complex (MHC) class II ␤ ␤ chain sequences exhibit two conserved tryptophan residues separated by 22 amino acids. Inspection of this motif in the X-ray structure of DR3 showed TrpTyr residues in the vicinity of the Ii-derived fragment CLIP. Five DR␤ ␤ mutants were produced. Mutation at Tyr123, Trp153 and Asp152 residues abolished interaction to the proline-rich sequence of Ii. All mutants formed heterodimers with DR␣ ␣, were capable of binding an antigenic sequence and were expressed on the cell surface of transfected cells. In the presence of endogenous DR␤ ␤ chain however, the TyrAspTrp mutant was not cell-surface exposed and did not co-isolate with Ii or DR␣ ␣. The competition of the mutant with the endogenous DR␤ ␤ for binding to DR␣ ␣ indicates that a structure on DR␤ ␤ chain regulates assembly of DR subunits. Hence, the chaperone function of Ii is mediated through a conserved region on the ␤ ␤2 domain of class II.
DR␤ chain modulates the chaperone function of Ii for class II folding and assembly.
Results

Search for a conserved invariant-chain-binding domain on MHCII␤ chains
Previously in the sequence of Ii, a polyproline was identified that interacts with HLA-DR and stabilizes the heterodimer (Stumptner and Benaroch, 1997; Siebenkotten et al., 1998 ). An example of a proline-binding sequence is the WW domain, which is named after a pair of strictly conserved tryptophans that are separated by 22 aa residues (Chen and Sudol, 1995; Zarrinpar and Lim, 2000) . In the search for a proline-binding sequence we found a highly conserved WWlike structure in the primary sequence of MHCII␤ chains of vertebrate species (Fig. 1A) . The sequence contains two Trp residues separated by 22 aa residues and two conserved Tyr residues. The resolved crystal structure of DR molecules showed that despite the distant location of the Tyr and Trp residues in the primary sequence (Trp153 and Tyr123 or Trp131 and Tyr171), both Trp and Tyr pairs form pocket-like structures that resemble the pair of TrpTyr residues in WW domains (Fig. 1B) (Bork and Sudol, 1994) . The threedimensional structure of the WW-defined motif in the ␤2 domain of DR␤ chain differs however from the WW domain (see Discussion). To distinguish the DR␤ sequence from the WW domain we designated this novel motif as WWCII (WW class II). The X-ray crystal structure of DR3 with bound CLIP (aa 81-101) revealed that the N-terminus of the Ii-derived peptide, containing the proline-rich region, was resolved only at residue Pro87 (Ghosh et al., 1995) . Fig. 1 shows that Pro87 of Ii is directed towards the pocket-like structure formed by the Trp153 and Tyr123 residues of the DR␤ chain. It is possible that the aromatic surface-exposed Journal of Cell Science 119 (20) residues Trp153 and Tyr123 arrange a binding site for adjacent residues of the proline-rich Ii sequence (aa 82-87). In addition, the position of the acidic Asp152 residue, which could interact with the basic Lys83 residue of Ii, is shown (Fig. 1B) .
Mutation of the WWCII sequence of the DR␤ chain To identify residues important for interaction of DR␤ chains with the proline-rich sequence of Ii, we introduced mutations into the ␤ chain of the DR1 allotype. The DR1␤ chain was mutated at Tyr123, Trp153 or Asp152, at both Tyr123 Trp153 and at Tyr123, Trp153 and Asp152 residues (compare Fig. 1A with 1B). Asp152 was mutated to examine interaction of the acidic residue with basic Lys residues of Ii. The Tyr, Trp and Asp residues were changed to Ala. To examine whether the mutated ␤ chains from DR1 form dimers with the nonpolymorphic DR␣ chain, cDNAs encoding mutated ␤ and ␣ chains were transiently expressed in COS-7 cells. Cells were labeled for 30 minutes with [ 35 S]methionine and lysed with NP40. DR heterodimers were immunoprecipitated with I251. This mAb detects a conformation-sensitive epitope on the DR␤ chain and binds when the DR␣␤ dimer is formed. Fig. 2A demonstrates isolation of the mutant DR molecules with I251 (lanes 1 to 5). For comparison, wild-type DR was separated in lane 6. The result in Fig. 2A indicates that all mutant DR1␤ chains exhibit extensive folding and dimerisation with the DR␣ chain.
To examine whether the introduced mutations affect the overall folding of the ␣1␤1 domain of DR, we tested whether the MHCII groove formed by the mutated DR1 heterodimer is capable of binding antigenic sequences. We used a recombinant Ii chain where the complete MHCII-binding site, including the proline-rich sequence, was replaced by a DR1-specific sequence derived from a matrix protein from influenza Conserved amino acid residues are colored in gray. (B) A potential proline-binding sequence of the DR␤ chain is adjacent to the proline-rich sequence of Ii. The X-ray structure of HLA-DR3 loaded with CLIP is shown. The YWD residues of WWCII are indicated (pdb accession 1A6A). Amino acid residues DR␤W153 and DR␤Y123 form a hydrophobic cluster that is exposed to a potential position of the proline-rich region of Ii. Residues DR␤W131 and DR␤Y171 form a cluster that is imprinted in the sequence of other members of the Ig super gene family. The P87 residue of CLIP is resolved in the X-ray structure. The X-ray structure was modified with Swiss-Deep view3.7 and visualized with Viewer Lite5.0 (right).
virus (MAT). Binding of Ii-MAT to MHCII heterodimers occurs in the endoplasmic reticulum and does not depend on antigen processing or on the function of DM. Previously, we showed that Ii-MAT-DR1 complexes are stable in NP40, whereas Ii-MAT-DR4 complexes could not be detected, indicating that Ii-MAT binds allotype specifically to DR1 (Siebenkotten et al., 1998) . COS-7 cell were transfected with DR␣, with mutant or wild-type DR␤, and with IiMATencoding cDNAs. In Fig. 2B mutated DR1 heterodimers and wild-type DR1 were immunoprecipitated. The co-isolated Ii-MAT was detected by western blotting with a mAb specific for Ii. Note that all DR1 mutants co-isolate Ii-MAT. The result indicates that the peptide-binding cleft of the mutated DR1 heterodimer binds to an antigenic sequence, such as the MAT sequence. Fig. 2B (lane 6) suggests that binding of the TyrTrpAsp mutant DR␤ to Ii is reduced compared with wtDR (lane 1), which could indicate some conformational change of the TyrTrpAsp mutated DR␤ chain affecting the peptide binding groove.
Deletion of the proline-rich sequence of Ii inhibits interaction with WWCII on the DR␤ chain
The five DR1 mutants Tyr123, Asp152, Trp153, Tyr123Trp153 and Tyr123Trp153Asp152, were tested for binding to fulllength Ii. For comparison, co-isolation of full-length Ii with wild-type DR␣␤ dimers is shown in Fig. 3A (upper panel, lane 1). Fig. 3A (upper panel, lanes 4, 7, 10, 13 and 16) shows that immunoprecipitation of the mutant DR1 heterodimers coisolates Ii, which was monitored by western blotting. Thus, Ii is capable of binding to dimers of mutant DR1␤ chains with DR␣. To examine interaction of the proline-rich sequence of Ii with MHCII, we constructed recombinant Ii chains, where the MHCII-groove-binding site at aa 91-99 was mutated. In the Ii91-99 mutant, the groove-binding sequence of Ii was replaced by a sequence that contains no binding motif for DR1. This sequence was extended further in the Ii82-99 mutant to replace the proline-rich sequence. DR immunoprecipitates from COS-7 cells transfected with wild-type DR, with DR mutants and with Ii91-99 showed detection of the recombinant Ii (Fig. 3A, upper panel, lanes 2, 5, 8, 11 and 14) , except for the TyrTrpAsp DR␤ mutant (lane 17). DR heterodimers composed of DR␣ and TyrTrpAsp mutant DR␤ bound wild-type Ii but not the mutant Ii91-99 that contains the proline-rich sequence and no MHCII-groove-binding sequence. This result indicates that Ii91-99 binds to DR␣␤ heterodimers and suggests that aa residues 82-90 of Ii are important for binding to the complex. The Ii82-99 mutant that contains no proline-rich sequence showed almost no binding to wild-type DR and no co-isolation with the mutant DR heterodimers was detected (Fig. 3A , lanes 3, 6, 9, 12, 15 and 18). Expression of the transfected polypeptides was examined by western blotting of cell lysates (lower part of Fig. 3A) . Isolation of ␣␤ dimers was achieved by using a conformation-sensitive mAb, which selectively immunoprecipitates DR heterodimers. To estimate the relative amount of Ii chain co-precipitated with DR, the band intensity of co-isolated Ii was compared with Ii expression in the corresponding cell lysate.
To verify the nature of binding of Ii to DR heterodimers, an additional allotype was examined. Tyr123Trp153Asp152 residues of DR3␤ were mutated to Ala123Ala153Ala152. The mutant DR3␤ chain was co-expressed with DR␣ and tested for binding to recombinant Ii chains. The DR␣ DR3␤ heterodimer with mutated TyrTrpAsp binds to wild-type Ii (Fig. 3B , lane 4), albeit with reduced strength, but shows no binding to mutants Ii91-99 (Fig. 3B, lane 5) or Ii82-99 (lane 6) The experiment in Fig. 3B demonstrates that the WWCII sequence of DR3 impacts on binding to Ii.
The impact of TyrTrpAsp DR␤ mutation on the assembly and transport of DR heterodimers We examined, whether the TyrTrpAsp-mutated DR heterodimer is intracellularly transported in transfected cells. To monitor intracellular transport, the Asn-linked carbohydrate on DR␤ chain, which is modified upon transport to Golgi compartments and there acquires endonuclease (Endo) H resistance was examined. In 2, 3 and 7) of Ii. Cells were lysed and DR was immunoprecipitated with mAb I251. Immunoprecipitates were digested with Endo H (E H ) (lanes 2 and 5), with PNgase F (P F ) (lanes 3 and 6) or left untreated (Ø) (lanes 1 and 4) . Subsequently the samples were separated by SDS-PAGE and immunoblotted with S35 for DR␤. Lanes 7 and 8 show cell lysates western blotted for DR␣. Ii was immunodetected in lane 9. (B) Endo H digestion of transfected DR␤ chains. MelJuso cells were transfected with V5-tagged wtDR␤ (lanes 1-3) , or the mutants DR␤Y (lanes 4-6), DR␤W (lanes 7-9), DR␤D (lanes 10-12), DR␤YW (lanes 13-15) and DR␤YWD (lanes 16-17). Lysates were digested with EndoH or PNGaseF and analyzed by western blotting for the presence of the V5-tagged DR␤ chains. (C) Cellular distribution of DR␤ chains. MelJuso cells were transfected with V5-tagged DR␤YWD, with wtDR␤ or with empty expression vector (mock). Expression was monitored by double immunofluorescence staining of the cells with mAb V5 or DR mAb I251 (red staining, top row) and with an antibody against Cath B (green staining, middle row). In the bottom row, staining of rows 1 and 2 were merged. Nuclei were counterstained with DAPI. (D) MelJuso cells expressing V5-tagged wtDR␤ or YWD-mutated DR␤ were surface biotinylated and lysed with NP40. Cell lysates with wtDR␤ or YWD-mutated DR␤ were separated in lanes 3 and 4 or subjected to immunoprecipitation with V5 mAb. DR␤ chains were immunoblotted with streptavidin peroxidase (lanes 1 and 2) or with V5 mAb. (E) Coimmunprecipitation of DR␤ with Ii. MelJuso cells were transfected with V5-tagged wtDR␤ or V5-tagged mutant DR␤YWD. Ii was immunoprecipitated with polyclonal antibody S22 and the immunocomplexes were detected by western blotting with mAb V5 for the presence of wtDR␤ (lane 1) or DR␤YWD (lane 3). Expression of the V5-tagged ␤ chains was examined by western detection of the lysates (lanes 2 and 4). (F) Western blotting of DR␣ immunoisolated with YWD mutant DR␤ chain expressed in the presence or absence of wtDR␤. IMRS cells were transfected with DR␣, DR␤YWD, Ii and wtDR␤ (lane 2) or with a vector control (lane 1). DR␤YWD was immunoprecipitated and the immunocomplexes were western blotted for the presence of DR␣. Expression of the individual molecules was examined by western blotting of the lysates with mAb 1B5 (DR␣; lanes 4 and 5), mAb V5 (DR␤YWD; lanes 6 and 7) and mAb 6D4 (wtDR␤; lane 8).
6, in addition to ␣ and ␤ chains, Ii was co-expressed. In the presence of Ii, wild-type DR␤ chain acquires almost complete resistance to Endo H digestion indicating that Ii is a chaperone for MHCII molecules (lane 5, upper panel). Expression of Ii however, did not increase the amount of Endo-H-resistant TyrTrpAsp-mutated DR␤ chain (lane 5, lower panel). This result indicates that expression of Ii did not enhance transport of the TyrTrpAsp-mutated DR molecules as shown for wildtype DR. Lanes 7 and 8 show expression of the ␣ chain and lane 9 of Ii chain in cell lysates. We conclude that contact of Ii to WWCII is required to facilitate intracellular transport of DR heterodimers. Interaction of the proline-rich region of Ii to WWCII on the DR␤ chain could be important to accomplish assembly of MHCII subunits.
To examine whether the WWCII domain impacts on DR assembly, we transfected MelJuso cells with mutant DR␤ or with wild-type DR␤ chains encoding cDNAs. MelJuso cells express HLA-DR and Ii polypeptides endogenously. Therefore, the transiently expressed DR␤ chains will compete with endogenous DR␤ chains for binding to DR␣. Transfected MelJuso cells were lysed and lysates were subjected to Endo H ( Fig. 4B lanes 2, 5, 8 , 11, 14 and 17) or to PNgase F (lanes 3, 6, 9, 12, 15 and 18) treatment, or left untreated (lanes 1, 4, 7, 10, 13 and 16). The lysates were separated by SDS-PAGE and immunoblotted for the transiently expressed DR␤ chains. The V5-tagged wild-type DR␤ chain shows that a substantial proportion of this polypeptide contains Endo-H-resistant carbohydrates (lane 2). The glycan chains are completely To verify, that the TyrTrpAsp-mutated DR␤ chain is not expressed on the cell surface, MelJuso cells expressing V5-tagged wtDR␤ or TyrTrpAsp-mutated DR␤ chains were surface biotinylated (Fig. 4D) . Cell lysates separated in lanes 3 and 4 were blotted for V5-tagged DR␤ chains. This control indicates that similar amounts of V5-tagged wild-type and TyrTrpAsp-mutated DR␤ chains were expressed by the transfected MelJuso cells. Immunoprecipitation of the V5-tagged DR␤ chains (lanes 1 and 2) and subsequent detection of biotinylated DR showed that only wtDR was detected (lane1). The TyrTrpAsp-mutated DR␤ chain was not isolated from cell-surface-labeled MeJuso cells (lane 2).
We investigated whether the transiently expressed DR␤ chains are contained in complexes with Ii. Ii was immunoprecipitated from MelJuso cells, which transiently express V5-tagged wild-type or TyrTrpAsp mutant DR␤ chains. Fig. 4E , lanes 1 and 3 show Ii immunoprecipitates and lanes 2 and 4 cell lysates, which were immunoblotted for the transiently expressed DR␤ chains. V5-tagged DR␤ chain coisolates with Ii (lane 1), whereas the TyrTrpAsp DR␤ mutant was not detected in Ii immunoprecipitates (lane 3). Immunoblotting of cell lysates revealed that similar amounts of both V5-tagged DR␤ chains were expressed (lanes 2 and 4) . This result suggests that in MelJuso cells, the TyrTrpAspmutated DR␤ chain is not contained in a complex with Ii and possibly not with DR␣. To examine whether interaction of TyrTrpAsp-mutated DR␤ with DR␣ is influenced by expression of wild-type DR␤, we used human IMRS cells, which do not express endogenous MHCII or Ii. IMRS cells were transfected with DR␣, TyrTrpAsp-mutated DR␤, Ii and with or without cDNAs encoding wild-type DR␤ (Fig. 4F) . The V5-tagged TyrTrpAsp mutant was immunoprecipitated and immunoblotted with mAb for DR␣. In the absence of wild-type DR␤, the TyrTrpAsp mutant co-isolates DR␣ (lane 1). Coexpression of wild-type DR␤ (lane 2) strongly reduces the coisolation of DR␣ with the TyrTrpAsp mutant. Expression of the transiently expressed polypeptides is shown in lanes 4 to 8. This result indicates that the transfected wild-type DR␤ chain almost completely inhibits binding of the TyrTrpAsp mutant DR␤ chain to DR␣.
Discussion
A novel domain on the DR␤ chain regulates the chaperone role of invariant chain The invariant chain facilitates assembly and subsequent intracellular transport of DR molecules. In the absence of Ii, DR subunits form aggregates that are retained in the ER and only a proportion of DR␣␤ heterodimers acquires a transportcompetent conformation and is exposed on the cell surface (Marks et al., 1995) . Interaction of Ii with the MHCI groove appears to chaperone assembly of MHCII subunits (Romagnoli and Germain, 1994) . A peptide, covalently bound to the Nterminus of ␤ chain was shown to stabilize class II ␣␤ dimers (Kozono et al., 1994) . These tethered ␣␤-peptide complexes are detected on the cell surface of transfected B cells or fibroblast cells. Surface expression of functional class II peptide receptors could suggest that binding of a peptide to the class II groove is sufficient to chaperone assembly of ␣␤ dimers. However, further studies indicated that this ␣␤-peptide complex has a binding site for Ii other than the peptide-binding groove, suggesting a role of Ii for surface expression of the tethered ␣␤-peptide complex (Wilson et al., 1998) . This observation is consistent with our finding that interaction of Ii with MHCII is mediated by conserved residues in the ␤2 domain of the ␤ chain.
In this report we describe a novel domain (WWCII) on the DR␤ chain, which provides an additional binding site for Ii. We suggest that interaction of Ii with WWCII on DR␤ chain facilitates folding and subsequent intracellular transport of DR heterodimers. Alteration of this domain by site-directed mutagenesis results in ␣␤ dimers, which are isolated by a mAb that reacts to the heterodimer but not to single DR chains. In addition, the mutated ␣␤ dimers bind to an antigenic sequence contained in an Ii fusion protein, although the TyrTrpAsp mutant DR␤ chain binds with reduced affinity. Moreover, it was shown that in transfected IMRS cells, the TyrTrpAspmutated DR heterodimer is transported, which was demonstrated by Endo H resistance of the ␤ chain. Hence, despite the mutations, important molecular functions of class II are maintained. Our results indicate that interaction of the proline-rich sequence of Ii to DR dimers is abolished by mutation of TyrTrpAsp residues on the DR␤ chain. This was concluded, because a groove-binding-sequence-deleted Ii chain did not bind to the TyrTrpAsp-mutated DR1 and to the DR3 allotypes. The importance of WWCII for class II assembly was demonstrated by transfection of MelJuso cells, which express endogenous DR chains, with the TyrTrpAspmutated DR␤ cDNA. In these cells, endogenous DR␤ chain out-competes binding of TyrTrpAsp-mutated DR␤ to DR␣. In contrast to the other mutants in MelJuso cells, the TyrTrpAsp-mutated DR␤ chain is not transported and is not contained in complexes with Ii. This latter finding is consistent with the observation that Ii does not co-isolate with single DR␤ chain (Neumann and Koch, 2005) . The role of Ii for assembly of DR␣ with wtDR␤ was demonstrated by transfection of IMRS cells, which are negative for Ii and DR. Only in the presence of Ii, was the wtDR␤ chain capable of competing with the TyrTrpAsp-mutated DR␤ chain for binding to DR␣. Hence, we suggest that interaction of Ii with WWCII on the DR␤ chain governs the chaperon function of Ii.
A binding site for invariant chain is located on the ␤2 domain of DR␤ chain Our data suggest that the WWCII architecture on MHCII molecules provides a platform for the binding of residues 82-87 of Ii. We discovered the WWCII sequence by comparison of MHC class II ␤ chain sequences to a WW motif found in a family of proteins. Comparison of the WW domain of dystrophin as a member of the WW protein family (Zarrinpar and Lim, 2000; Huang et al., 2000) with MHCII␤ chain sequences revealed in both sequences two tryptophans at a distance of 22 aa residues. The WWCII sequence contains a pair of conserved W residues at position 131 and 153 of the DR␤ chain. The structure of WWCII however differs from the WW domain. WWCII, with a size of at least 50 residues, is larger than the WW motif with 38 to 40 residues. A WW domain, as found in dystrophin, adopts an anti-parallel three-stranded fold, where the second Trp residue forms a hydrophobic pocket with a Tyr residue. The groove formed by the conserved Tyr and Trp residues is composed of nearly parallel aromatic residues where a proline-rich motif could bind. In contrast to the WW protein family, in WWCII the pair of Trp residues is flanked by sequences containing Tyr123 and Tyr171 residues. The upper pocket consisting of Trp153 and Tyr123 residues is directed towards the surface, whereas the hydrophobic pocket formed by Tyr171 and Trp131 is completely turned to the inside of the molecule. The membrane proximal Trp131 and Tyr171 pair is part of the Ig-domain structure and a similar structure is found in the protein sequence of other members of the Ig super gene family. The pair of Trp153 and Tyr123 residues however, is contained only in the sequence of the MHCII␤ chains.
The WWCII structure on MHCII ␤ chains may define a novel protein motif that interacts with proline-containing sequences. For comparison, WW domains contain Trp and Tyr residues, which form binding pockets for proline residues. WW domains have highly diverse sequence preferences and binding of Pro residues depends on adjacent residues. The proline-rich sequence motif of human Ii matches the sequence of the group III WW motif, where polyproline is flanked by Lys or Arg residues (Bedford et al., 2000; Sudol and Hunter, 2000) . In WWCII, the Trp153 and Tyr123 residues partially define the binding sequence to the proline-rich sequence of Ii. For the proline-rich motif ProLysProProLysPro corresponding to residues 82-87 of human Ii, it was shown that mutation of the flanking Pro and of Lys, to Leu residues strongly reduced binding of this sequence to DR molecules (Sievers et al., 2002) . The Lys residues are conserved in the proline-rich Ii sequence of six mammalian species. It is possible that a positively charged Lys residue of Ii interacts to a negatively charged residue on the DR␤ chain. The tertiary structure of HLA-DR␤ chains revealed Trp153 and adjacent Tyr123 as conserved residues. In addition to the TrpTyr pocket, the ⑀ carboxyl group of Asp152 is accessible for inter-chain contacts. Thus, interaction of Lys83 of Ii, with Asp152 of the DR␤ chain might be possible. We therefore suggest that interaction of WWCII to Ii depends on binding of TrpTyr and Asp residues on DR␤ chain to Pro and Lys residues on Ii.
We found a novel domain on DR␤ chains that mediates contact with a proline-rich sequence of Ii. The conserved WWCII sequence may play a central role for assembly of ␣, ␤ and Ii subunits. In antigen-presenting cells, where the numerous class II subunits of various allo-and isotypes are expressed, association of matched ␣ and ␤ heterodimers could be monitored by interaction of Ii with WWCII on the ␤ chain.
Materials and Methods
PCR-based mutagenesis
The coding sequence for HLA-DR1*010101, HLA-DR3*030101 beta chains and of human Ii were subcloned from pCEXV3 into expression vector pcDNA3.1(-) and were used as template for PCR mutagenesis. The residues Tyr123, Trp153 and Asp152 of DR␤ were mutated to Ala. Mutation of all three residues within the same chain was obtained by introducing the mutation for Asp152Ala and Trp153Ala with one pair of mutagenic primers, while the third mutation Tyr123Ala was introduced sequentially. For each DR1 construct, two fragments encompassing the mutation were PCR-amplified in reactions containing either DR1uni (5Ј-CACCATGG-TACCGTGCACGCTGCTC-3Ј) and the mutagenic anti-sense primers or DR1rev (5Ј-TCAGCTCAGGAATCCTGTTGG-3Ј) and the mutagenic sense primers. The mutagenic sense and anti-sense primers are as follows: W131Auni (5Ј-CTGG-CCGTTCCGGAACGCCCTGACTTCAATGC-3Ј); W131Arev (5Ј-GCATTGAAG-TCAGGCGTTCCGGAACGGCCAG-3Ј); D152Auni (5Ј-CTGATCCAGAATGG-AGCTTGGACCTTCCAG-3Ј); D152Arev (5Ј-CTGGAAGGTCCAAGCTCCA-TTCTGGATCAG-3Ј); Y123Auni (5Ј-GTGAGTGGTTTCGCTCCAGGCAGC-3Ј); Y123Arev (5Ј-GCTGCCTGGAGCGAAACCACTCAC-3Ј), D152A.W153Auni
Immunofluorescence microscopy
For immunofluorescence staining, cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. The cells were blocked with 10% BSA and stained with the primary antibody, followed by Alexa Fluor-labeled secondary antibodies [goat anti-mouse IgG (594 nm) or goat anti-rabbit IgG (488 nm)]. The cells were mounted with Mowiol and visualized by fluorescence microscopy (Axiophot, Zeiss).
Transfection
MelJuso cells and IMRS cells were transfected with the transfection reagent JetPei (QbioGene). The cells were transfected in a six-well culture plate at 50% confluence. The DNA-polyethylenimine complexes were prepared as recommended by the supplier. COS-7 cells were transfected with the liposomal transfection reagent DOSPER (Roche) . DNA mixed with DOSPER was incubated for 20 minutes and added to cells. After 48 hours, transfected cells were harvested and subjected to immunoprecipitation, metabolic radiolabeling or immunofluorescence microscopy.
Metabolic radiolabeling and immunoprecipitation
Cells were incubated in methionine-free medium for 45 minutes and labelled for 15 minutes with 50 Ci [ 35 S]methionine as recently described (Neumann et al., 2001 ). Cells were lysed in 0.5% NP40 (Sigma) in 20 mM Tris-HCl, pH 7.4 and precleared with CL4B-Sepharose (Amersham Pharmacia); immunoprecipitation was performed with protein-A-Sepharose. Samples were analyzed by reducing SDS-12% PAGE followed by autoradiography or western blotting of unlabeled cells. Transfected MelJuso cells were biotinylated with Sulfo-Biotin-7-NHS according to the instruction of the supplier (Pierce, Bonn, Germany). In brief, 1ϫ10 7 cells were suspended in 1 ml biotinylation buffer (50 mM boric acid and 150 mM NaCl). 10 l sulfosuccinimidyl-7-biotinamido-6-hexanamidohexanoate (10 mg/ml in H 2 O) were added and incubated for 15 minutes. The reaction was stopped by addition of 20 l of 100 mM NH 4 Cl. The samples were washed twice in ice-cold PBS and stored at -70°C.
Immunoblotting
Cell lysates were prepared with 0.5% NP40 in PBS with 10 mM Tris-HCl, pH 7.4 containing Complete (Roche) protease inhibitor mix. The samples were separated by reducing SDS-12% PAGE and electrophoretically transferred onto an Immobilon P membrane (Millipore). The membrane was blocked for 1 hour in PBS-RotiBlock (Roth), washed with PBS-0.2% Tween 20 and probed with the primary antibody followed by the peroxidase-conjugated secondary antibody and ECL chemiluminescent substrate (Pharmacia).
